# The Procter & Gamble Company (PG) Q4 2025 Financial Results Summary
**Release Date:** July 29, 2025
The Procter & Gamble Company (NYSE: PG) announced its fourth quarter and fiscal year 2025 results, highlighting continued growth in a challenging environment. Here is a summary of the key financial metrics and developments from the report.
### Fiscal Year 2025 Highlights
– **Net Sales:** $84.3 billion
– **Change:** Unchanged vs. FY 2024
– **Organic Sales:** Increased by **2%** (compared to the prior fiscal year)
– **Diluted EPS:** $6.51
– **Change:** Increased by **8%** vs. FY 2024
– **Core EPS:** $6.83
– **Change:** Increased by **4%** vs. FY 2024
### Q4 2025 Highlights
– **Net Sales:** $20.9 billion
– **Change:** Increased by **2%** vs. Q4 2024
– **Organic Sales:** Increased by **2%**
– **Diluted EPS:** $1.48
– **Change:** Increased by **17%** vs. Q4 2024
– **Core EPS:** $1.48
– **Change:** Increased by **6%** vs. Q4 2024
### Cash Flow & Shareholder Returns
– **Operating Cash Flow for FY 2025:** $17.8 billion
– **Net Earnings for FY 2025:** $16.1 billion
– **Adjusted Free Cash Flow Productivity:** **87%**
– **Total Return to Shareholders:** Over $16 billion
– **Dividends Paid:** $9.9 billion (an increase of **5%** from the previous year)
– **Share Repurchases:** $6.5 billion
– **Dividends and Share Repurchase Milestone:**
– Marked the **69th consecutive year** of dividend increases and the **135th consecutive year** of dividend payments.
### Segment Performance Overview (Q4 2025)
– **Beauty Segment:**
– **Organic Sales:** Increased by **1%**
– **Grooming Segment:**
– **Organic Sales:** Increased by **1%**
– **Health Care Segment:**
– **Organic Sales:** Increased by **2%**
– **Fabric & Home Care Segment:**
– **Organic Sales:** Increased by **1%**
– **Baby, Feminine & Family Care Segment:**
– **Organic Sales:** Increased by **1%**
### Cost Structure
– **Gross Margin:** Decreased by **50 basis points** vs. Q4 2024
– **Core Gross Margin:** Decreased by **70 basis points** vs. Q4 2024
– **SG&A Expenses:** Decreased by **240 basis points** as a percentage of sales
### Forward-Looking Guidance
– **Fiscal Year 2026 Expectation:**
– **Sales Growth:** Projected in the range of **1% to 5%**
– **Organic Sales Growth:** Expected range of flat to **up 4%**
– **Diluted EPS Growth:** Estimated between **3% to 9%**
– **Core EPS Growth:** Expected to be flat to **up 4%**
– **Dividend Payment Anticipation:** Around $10 billion
– **Share Repurchase Estimation:** Approximately $5 billion
### Additional Remarks
– The company plans to continue focusing on a **streamlined product portfolio** and executing a new **productivity and cost structure plan**, particularly in the context of ongoing macroeconomic challenges.
– P&G also completed a **limited market portfolio restructuring** impacting several international markets, aiming to better manage economic volatility.
### Conclusion
The Procter & Gamble Company has demonstrated resilience with its fiscal 2025 results, showcasing sales growth and earnings improvement while committing to shareholder value through dividends and share buybacks. Looking forward, P&G anticipates continued growth amidst challenges posed by the economic landscape.
Here are the extracted tables from the press release:
### Condensed Consolidated Statements of Income
(Amounts in Millions Except Per Share Amounts)
| Three Months Ended June 30 | Fiscal Year Ended June 30 | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| NET SALES | $ 20,889 | $ 20,532 | $ 84,284 | $ 84,039 |
| Cost of products sold | 10,631 | 10,348 | 41,164 | 40,848 |
| GROSS PROFIT | 10,258 | 10,183 | 43,120 | 43,191 |
| Selling, general and administrative expense | 5,903 | 6,299 | 22,669 | 23,305 |
| Indefinite intangible asset impairment charge | — | — | 1,341 | — |
| OPERATING INCOME | 4,355 | 3,884 | 20,451 | 18,545 |
| Interest expense | -212 | -220 | -907 | -925 |
| Interest income | 104 | 107 | 469 | 473 |
| Other non-operating income, net | 274 | 98 | 154 | 668 |
| EARNINGS BEFORE INCOME TAXES | 4,521 | 3,870 | 20,167 | 18,761 |
| Income taxes | 895 | 726 | 4,102 | 3,787 |
| NET EARNINGS | 3,626 | 3,144 | 16,065 | 14,974 |
| Less: Net earnings attributable to non-controlling interests | 11 | 7 | 91 | 95 |
| NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE | $ 3,615 | $ 3,137 | $ 15,974 | $ 14,879 |
| EFFECTIVE TAX RATE | 19.8% | 18.8% | 20.3% | 20.2% |
| NET EARNINGS PER COMMON SHARE: (1) | ||||
| Basic | $ 1.51 | $ 1.30 | $ 6.67 | $ 6.18 |
| Diluted | $ 1.48 | $ 1.27 | $ 6.51 | $ 6.02 |
| DIVIDENDS PER COMMON SHARE | $ 1.0568 | $ 1.0065 | $ 4.0763 | $ 3.8286 |
| Diluted Weighted Average Common Shares Outstand | 2,443.8 | 2,472.2 | 2,454.4 | 2,471.9 |
### Condensed Consolidated Balance Sheets
(Amounts in Millions)
| June 30, 2025 | June 30, 2024 | |
|---|---|---|
| Cash and cash equivalents | $ 9,556 | $ 9,482 |
| Accounts receivable | 6,185 | 6,118 |
| Inventories | 7,551 | 7,016 |
| Prepaid expenses and other current assets | 2,100 | 2,095 |
| TOTAL CURRENT ASSETS | 25,392 | 24,709 |
| PROPERTY, PLANT AND EQUIPMENT, NET | 23,897 | 22,152 |
| GOODWILL | 41,650 | 40,303 |
| TRADEMARKS AND OTHER INTANGIBLE ASSETS, NET | 21,910 | 22,047 |
| OTHER NONCURRENT ASSETS | 12,381 | 13,158 |
| TOTAL ASSETS | $ 125,231 | $ 122,370 |
| Accounts payable | $ 15,227 | $ 15,364 |
| Accrued and other liabilities | 11,318 | 11,073 |
| Debt due within one year | 9,513 | 7,191 |
| TOTAL CURRENT LIABILITIES | 36,058 | 33,627 |
| LONG-TERM DEBT | 24,995 | 25,269 |
| DEFERRED INCOME TAXES | 5,774 | 6,516 |
| OTHER NONCURRENT LIABILITIES | 6,120 | 6,398 |
| TOTAL LIABILITIES | 72,946 | 71,811 |
| TOTAL SHAREHOLDERS’ EQUITY | 52,284 | 50,559 |
| TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | $ 125,231 | $ 122,370 |
